Cambridge Investment Research Advisors »

Tscan Therapeutics shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $80k 10k 7.95

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corp Com (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Value Etf (VTV)

View all positions for Cambridge Investment Research Advisors

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
EcoR1 Capital
BVF
Baker Bros. Advisors
Propel Bio Management
Vanguard Group
Deer Management
Alphabet
Simplify Asset Management
Standard Life Aberdeen
Stifel Financial
Marshall Wace
Millennium Management
NewEdge Wealth
Jane Street

View all funds holding Tscan Therapeutics